Doximity, Inc. DOCS
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 661.58M | 655.57M | 644.86M | 637.78M | 621.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 661.58M | 655.57M | 644.86M | 637.78M | 621.33M |
| Cost of Revenue | 87.15M | 78.23M | 70.33M | 65.39M | 60.87M |
| Gross Profit | 574.43M | 577.34M | 574.54M | 572.39M | 560.46M |
| SG&A Expenses | 239.29M | 232.92M | 220.41M | 215.10M | 207.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 480.58M | 453.53M | 421.44M | 396.88M | 372.39M |
| Operating Income | 181.01M | 202.04M | 223.42M | 240.90M | 248.94M |
| Income Before Tax | 203.61M | 226.22M | 250.01M | 276.28M | 285.32M |
| Income Tax Expenses | 63.89M | 59.18M | 53.95M | 36.88M | 32.29M |
| Earnings from Continuing Operations | 139.72 | 167.05 | 196.05 | 239.40 | 253.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 139.72M | 167.05M | 196.05M | 239.40M | 253.03M |
| EBIT | 181.01M | 202.04M | 223.42M | 240.90M | 248.94M |
| EBITDA | 189.27M | 210.02M | 230.41M | 247.08M | 254.18M |
| EPS Basic | 0.76 | 0.90 | 1.05 | 1.27 | 1.35 |
| Normalized Basic EPS | 0.71 | 0.79 | 0.86 | 0.93 | 0.96 |
| EPS Diluted | 0.72 | 0.85 | 0.99 | 1.20 | 1.26 |
| Normalized Diluted EPS | 0.68 | 0.74 | 0.81 | 0.87 | 0.89 |
| Average Basic Shares Outstanding | 733.57M | 742.60M | 748.02M | 751.53M | 751.21M |
| Average Diluted Shares Outstanding | 773.22M | 786.16M | 796.15M | 804.11M | 807.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |